Patient Opportunity Trust Class C
LMOPX
NASDAQ
| Weiss Ratings | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Fair | |||
| Reward Grade | C | |||
| Risk Index | Weak | |||
| Risk Grade | D+ | |||
| Company Info | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Provider | Patient Capital Management | |||
| Manager/Tenure (Years) | Samantha McLemore (18), Christina Malbon (3) | |||
| Website | http://www.patientcapitalmanagement.com | |||
| Fund Information | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Fund Name | Patient Opportunity Trust Class C | |||
| Category | Mid-Cap Value | |||
| Sub-Category | US Equity Mid Cap | |||
| Prospectus Objective | Growth | |||
| Inception Date | Dec 30, 1999 | |||
| Open/Closed To New Investors | Closed | |||
| Minimum Initial Investment | 1,000.00 | |||
| Minimum Subsequent Investment | 50.00 | |||
| Front End Fee | -- | |||
| Back End Fee | 0.01 | |||
| Dividends and Shares | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield | 0.00% | |||
| Dividend | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Yield (Forward) | 1.07% | |||
| Asset Allocation | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Cash | -0.19% | |||
| Stock | 97.74% | |||
| U.S. Stock | 90.87% | |||
| Non-U.S. Stock | 6.87% | |||
| Bond | 0.00% | |||
| U.S. Bond | 0.00% | |||
| Non-U.S. Bond | 0.00% | |||
| Preferred | 0.48% | |||
| Convertible | 0.00% | |||
| Other Net | 1.96% | |||
| Price History | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 0.12% | |||
| 30-Day Total Return | -1.93% | |||
| 60-Day Total Return | 3.88% | |||
| 90-Day Total Return | 6.66% | |||
| Year to Date Total Return | 14.03% | |||
| 1-Year Total Return | 16.93% | |||
| 2-Year Total Return | 58.25% | |||
| 3-Year Total Return | 107.23% | |||
| 5-Year Total Return | 43.65% | |||
| Price | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Closing Price | -- | |||
| 1-Month Low Price | -- | |||
| 1-Month High Price | -- | |||
| 52-Week Low Price | -- | |||
| 52-Week Low Price (Date) | -- | |||
| 52-Week High Price | -- | |||
| 52-Week High Price (Date) | -- | |||
| NAV | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Nav | $48.68 | |||
| 1-Month Low NAV | $48.04 | |||
| 1-Month High NAV | $50.34 | |||
| 52-Week Low NAV | $38.17 | |||
| 52-Week Low NAV (Date) | Mar 30, 2026 | |||
| 52-Week High NAV | $50.34 | |||
| 52-Week High Price (Date) | Aug 27, 2026 | |||
| Beta / Standard Deviation | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 1.39 | |||
| Standard Deviation | 20.70 | |||
| Balance Sheet | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Total Assets | 2.11B | |||
| Operating Ratios | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Expense Ratio | 2.44% | |||
| Turnover Ratio | 27.00% | |||
| Performance | LMOPX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
| Last Bull Market Total Return | 46.07% | |||
| Last Bear Market Total Return | -29.60% | |||